Neuroone Med Technologies Co.
13F holders, Q4 2024 (December 31)20holders −1
3new positions
5sold out
1famous investor
$0.83avg. 13F price*
At the end of Q4 2024, 20 institutions reported holding Neuroone Med Technologies Co. in their 13F filings, down 1 from Q3 2024. 3 opened new positions and 5 sold out. The largest holders were Vanguard Group Inc. ($760K), Geode Capital Management, LLC ($257K) and Citadel Advisors ($68K). One famous investor held it Ken Griffin (0.0% of Citadel Advisors's portfolio).
- Company
- Neuroone Med Technologies Co.
- CUSIP
- 64130M209
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q3 2024 → Q4 2024
| Institutions | Total Value | |
|---|---|---|
| New Positions | 3 | $111K |
| Exits | 5 | $951K |
All 13F filers, Q3 2024 → Q4 2024: 163,603 shares bought and 968,555 shares sold, net −804,952 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 20 holders
| Vanguard Group Inc. | 0.00% | No change | 919,528 | $760K |
| Geode Capital Management, LLC | 0.00% | Add +9.8% | 311,659 | $257K |
| Citadel Advisors | 0.00% | New | 81,802 | $68K |
| State Street Corp. | 0.00% | No change | 59,499 | $49K |
| Blair William & Co. | 0.00% | No change | 55,556 | $46K |
| MAI Capital Management | 0.00% | No change | 50,000 | $41K |
| Jane Street Group, LLC | 0.00% | New | 39,951 | $33K |
| Northern Trust Corp. | 0.00% | No change | 30,281 | $25K |
| XTX Topco Ltd | 0.00% | Reduce -29.9% | 18,520 | $15K |
| Princeton Global Asset Management LLC | 0.00% | No change | 16,833 | $14K |
| HRT Financial LP | 0.00% | New | 12,645 | $10K |
| Marcum Wealth, LLC | 0.00% | No change | 12,000 | $10K |
| Tower Research Capital LLC (TRC) | 0.00% | Add +32.2% | 5,747 | $5K |
| Farther Finance Advisors, LLC | 0.00% | No change | 2,500 | $2K |
| Osaic Holdings, Inc. | 0.00% | No change | 1,259 | $1K |
| Wells Fargo & Company | 0.00% | No change | 333 | $275 |
| Bank of America Corp. | 0.00% | Reduce -0.4% | 228 | $188 |
| UBS Group AG | 0.00% | No change | 108 | $89 |
| JPMorgan Chase & Co. | 0.00% | Reduce -4.3% | 66 | $55 |
| Vermillion Wealth Management, Inc. | 0.00% | — | 3 | $2 |
"% of holder's portfolio" is NEUROONE MED TECHNOLOGIES CO's weight in each manager's 13F, not the share of Neuroone Med Technologies Co. the manager owns.